The process of carcinogenesis involves sequential breakdown of extracellular matrix by a variety of proteolytic enzymes (Duffy, 1992) . Gelatinases, collagenases and stromelysins are metalloproteinases (MMPs), which are able to solubilise collagens in basement membranes and extracellular stroma (Matrisian, 1992) . This local proteolysis enables tumour cells to penetrate normal surrounding tissue. Immunohistochemical and in situ hybridisation studies in human gastrointestinal neoplasias have shown that these carcinomas contain enhanced amounts of matrix metalloproteinases (McDonnell et al., 1991; Poulsom et al., 1992; Grigioni et al., 1994) . The enhanced proteolytic capacity of tumour tissues is confirmed by studying tissue homogenates, using quantitative methods like activity assays, and ELISAs (Yamagata et al., 1991; Kimura et al., 1993; Duffy et al., 1995) . Some in vitro and in vivo experiments showed that matrix metalloproteinase levels were related to the invading and metastatic potential of colorectal cancer (Kimura et al., 1993; Emmert-Buck et al., 1994) . Moreover, plasma levels of some MMPs were found to be enhanced in patients with colonic cancer (Zucker et al., 1993) .
In this study we used a relatively straightforward method, gelatin zymography, to evaluate the presence of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) in stomach carcinomas and adjacent mucosa from 50 patients, from whom clinical and histopathological data concerning patients and carcinomas were available. Quantitative zymography has been shown previously to be an extremely reliable and sensitive technique for the detection of gelatinases (Kleiner and Stetler-Stevenson, 1994; Zucker et al., 1994 (Ganesh et al., 1996) . Representative samples of the carcinoma and macroscopically normal mucosa, taken 5-10 cm from the tumour, were frozen and stored at -70°C until extraction. Pathological and histological data of the tissues were re-evaluated by one pathologist (JvK). The patients entered the study at the date of surgery, did not receive adjuvant (chemo) therapy, and were clinically checked twice a year. Follow-up had to be at least 2 years and ended in the event of death or when still alive the last follow-up date before the common closing date (follow-up range 0.5-81 months).
Tissue extraction and protein concentration
Tissue specimens were homogenised in 0.1 M Tris-HCl, 0.1% (v/v) Tween 80 as described extensively previously (Sier et al., 1991; Ganesh et al., 1994a Ganesh et al., , 1996 . Protein concentrations of the supernatants were determined by the method of Lowry et al. (1951) .
Gelatin-zymography Presence of active and latent forms of matrix metalloproteinases was analysed by zymography on 10% polyacrylamide gels containing 2% gelatin and overnight incubation at 37°C, as described previously (Hanemaaijer et al., 1993 the carcinomas was significantly associated with a worse survival, exemplified by a shorter median survival time and a low percentage survival of the patients (Table I) . The mean levels of matrix metalloproteinases MMP-2 and MMP-9, as determined by EDTA-inhibitable gelatin-zymography (Figure 1 ), were significantly higher in carcinomas than in histologically confirmed tumour-free adjacent mucosa of the stomach, irrespective of MMP type or activity state (Table II) . Of the carcinomas, 82% (41/50) contained more total MMP-2 and 80% (40/50) contained more total MMP-9 than their corresponding mucosa, i.e. ratios higher than 1, as illustrated in Figure 2 . The enhanced amounts of MMPs in the carcinomas were not significantly correlated to any of the histological gastric tumour classification systems, although the carcinomas that were superficially invasive showed the lowest total MMP levels (MMP-2, 1.28 + 0.34; MMP-9, 2.49+1.18; in AU, n=4), and were similar to the mucosal levels. The total levels of MMP-2 and MMP-9 showed a relatively poor intercorrelation (mucosa r=0.19, NS; carcinomas r=0.34, P=0.01). For each of the MMP parameters in mucosa and carcinoma tissues the optimum cut-off values were determined using Cox's proportional hazards analyses (Table III) . In mucosa a significant cut-off value was found only for the active form of MMP-9 and indicated that a high level was associated with a good prognosis. In contrast, for the carcinomas, the total and the pro-forms of MMP-2 and MMP-9, as well as the active form of MMP-2 showed significant cut-off values revealing that high levels indicated a poor prognosis. Representative Kaplan-Meier curves for overall survival according to the cut-off points for total MMP-2 and MMP-9 are shown in Figures 3 and 4 . Table III shows the hazard ratios of all the significant MMP parameters according to Cox's proportional Figure 2 Individual data of the total MMP-2 and total MMP-9 ratio, carcinoma over mucosa, of the 50 gastric cancer patients. Dotted line indicates a ratio of 1, i.e. MMP level in carcinoma is identical to that of the gastric mucosa. of plasminogen activators, cathepsins and matrix metalloproteinases in different types of human carcinomas (McDonnell et al., 1991; Yamagata et al., 1991; Duffy, 1992; Matrisian, 1992; Poulsom et al., 1992; Kimura et al., 1993; Zucker et al., 1993; Emmert-Buck et al., 1994; Grigioni et al., 1994; Duffy et al., 1995) . In the present study we show that in a majority of gastric carcinomas the MMP-2 and MMP-9 levels are significantly higher than in the corresponding gastric mucosa, irrespective of the activity state of the enzymes. Moreover, our observation that the more deeply invasive carcinomas contain high levels of MMPs, whereas (Grigioni et al., 1994) . The levels of MMP-2 and MMP-9 showed a relatively poor intercorrelation, both in gastric mucosa and in carcinomas, suggesting an independent expression pattern for both proteinases, which is probably related to differences in the cellular origin of these enzymes (Matrisian, 1992) , but this was not assessed in the present study. Recently, the evaluation in carcinomatous tissue of some components of the plasminogen activation cascade, another important proteolytic system in carcinogenesis, has been found to be of significant value for the prognosis of cancer patients (Duffy et al., 1988; Janicke et al., 1991; Hasui et al., 1992; Ganesh et al., 1994a, and b; Nekarda et al., 1994; Pedersen et al., 1994) . Although the number of patients in the present study is relatively low, the results clearly show that high levels of MMP-2 and MMP-9 in stomach carcinomas are associated with a poor overall survival, which has never been reported before. The distinction between total, active and pro-form of MMPs in our study, as one of the important advantages of the zymographic analysis, seems to be particularly useful for MMP-2. The interpretation of the prognostic significance of MMP-9 in mucosa from patients with a gastric carcinoma is difficult. However, high levels of tissue-type plasminogen activator activity in normal colorectal and gastric mucosa were also found to be associated with a good prognosis in colorectal and gastric cancer patients (Ganesh et al., 1994a, and 1996) . The results of this study could have important clinical implications. Firstly, the prognostic significance of both MMPs in carcinomatous tissue is striking, especially in comparison with the relatively disappointing performance of established parameters like TNM and Lauren classification or diameter of the carcinoma. Therefore these proteolytic parameters may be suitable as prognosticators for the selection of patients for adjuvant therapy. Secondly, this study might give some rationale for therapeutic intervention with matrix metalloproteinase inhibitors, which has recently been demonstrated to be effective in patient-like orthotopic human tumour models in nude mice (Naito et al., 1994; Wang et al., 1994) .
